Your browser doesn't support javascript.
Phages in vaccine design and immunity; mechanisms and mysteries.
de Vries, Christiaan R; Chen, Qingquan; Demirdjian, Sally; Kaber, Gernot; Khosravi, Arya; Liu, Dan; Van Belleghem, Jonas D; Bollyky, Paul L.
  • de Vries CR; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States.
  • Chen Q; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States.
  • Demirdjian S; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States.
  • Kaber G; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States.
  • Khosravi A; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States.
  • Liu D; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States.
  • Van Belleghem JD; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States.
  • Bollyky PL; Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, CA, United States. Electronic address: pbollyky@stanford.edu.
Curr Opin Biotechnol ; 68: 160-165, 2021 04.
Article in English | MEDLINE | ID: covidwho-970472
ABSTRACT
Bacteriophages have attracted extensive interest in vaccine design. This includes the use of phage display technology to select antigens, the use of engineered phages displaying target antigens in vaccine formulations, and phage DNA vaccines. However, the development of these approaches is limited in part by uncertainty regarding the underlying mechanisms by which phages elicit immunity. This has stymied the clinical development of this technology. Here we review the immunology of phage vaccines and highlight the gaps in our knowledge regarding the underlying mechanisms. First, we review the basic biology of phages and their use in vaccines. Next we discuss what is known about the mechanisms of immunity against engineered phages and phage DNA. Finally, we highlight the gaps in our understanding regarding the immunogenicity of these preparations. We argue that mechanistic insight into the immunology of phage vaccines is essential for the further development and clinical utility of these technologies.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bacteriophages / Vaccines Type of study: Prognostic study Topics: Vaccines Language: English Journal: Curr Opin Biotechnol Journal subject: Biotechnology Year: 2021 Document Type: Article Affiliation country: J.copbio.2020.11.002

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Bacteriophages / Vaccines Type of study: Prognostic study Topics: Vaccines Language: English Journal: Curr Opin Biotechnol Journal subject: Biotechnology Year: 2021 Document Type: Article Affiliation country: J.copbio.2020.11.002